OPX Biotechnologies

  • NOTE: Cargill acquired OPX Biotechnologies’ fermentation-based processes and systems on April 28, 2015
  • Develops Efficiency Directed Genome Engineering (EDGE) platform to rationally bioengineer microbes for the production of bio-based chemicals; uses the Malonyl-CoA biosynthetic pathway...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Industrial Microbes

Company Profile | September 29, 2021

Genetically modifies E. coli to convert gas feedstocks like CO2 and methane into higher‑value chemicals Products of interest include 3‑hydroxypropionate (3‑HP) and its derivatives as well as novel polyhydroxyalkanoates (PHAs); developing other products with partners but would not disclose ... Not part of subscription

EnginZyme extends its Series A to €11 million

News Commentary | February 26, 2021

The funds will allow the company to further demonstrate the scalability of cell‑free production platforms. EnginZyme claims it has already produced catalysts at multi‑kg scales and operated pilots capable of producing 50 tons per year of product. While this is an impressive milestone, the company ... Not part of subscription

Avantium and Cosun Beet announce ambitious collaboration to scale plant-based glycols

News Commentary | April 29, 2021

Bio‑based routes to monoethylene glycol (MEG) have already been commercialized, but there are several ongoing efforts to develop lower‑cost routes. Avantium's Ray Technology is one example. The company claims to have developed a highly efficient process to produce MEG from plant‑based sugars. Being ... Not part of subscription